West Paces Advisors’s IRIDEX IRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-135
Closed -$134 375
2025
Q1
$134 Hold
135
﹤0.01% 554
2024
Q4
$227 Hold
135
﹤0.01% 540
2024
Q3
$236 Hold
135
﹤0.01% 534
2024
Q2
$292 Hold
135
﹤0.01% 549
2024
Q1
$402 Hold
135
﹤0.01% 554
2023
Q4
$379 Hold
135
﹤0.01% 579
2023
Q3
$343 Hold
135
﹤0.01% 505
2023
Q2
$293 Hold
135
﹤0.01% 534
2023
Q1
$281 Hold
135
﹤0.01% 542
2022
Q4
$271 Hold
135
﹤0.01% 522
2022
Q3
$325 Hold
135
﹤0.01% 509
2022
Q2
$347 Hold
135
﹤0.01% 563
2022
Q1
$625 Hold
135
﹤0.01% 545
2021
Q4
$825 Hold
135
﹤0.01% 551
2021
Q3
$1.03K Hold
135
﹤0.01% 558
2021
Q2
$953 Buy
+135
New +$1.03K ﹤0.01% 603

Other funds holding IRIX

West Paces Advisors's IRIX Position: Q2 2025 in Review

West Paces Advisors sold out of IRIDEX (IRIX) in Q2 2025, closing a stake of 135 shares — an estimated $134 sold.

West Paces Advisors first reported a position in IRIX in Q2 2021 and held it in 16 quarters. The position peaked at $1.03K in Q3 2021. 20 funds tracked by Wall St. Rank hold IRIX as of Q2 2025.

  • West Paces Advisors reported no remaining IRIDEX position as of Q2 2025 after selling out during the quarter.
  • West Paces Advisors sold 135 IRIDEX shares in Q2 2025, an estimated $134.
  • West Paces Advisors first reported a position in IRIDEX in Q2 2021 and held it in 16 quarters.
  • West Paces Advisors's IRIDEX position peaked at $1.03K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held IRIDEX as of Q2 2025.

Based on West Paces Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.